Antipsychotic Drug Exposure and Risk of Venous Thromboembolism: A Systematic Review and Meta-Analysis of Observational Studies

A Minimal Physiologically Based Model of the HPA Axis under Influence of the Sleep-Wake Cycles

(2013) S. Postnova et al.   PHARMACOPSYCHIATRY

Checklists of methodological issues for review authors to consider when including non-randomized studies in systematic reviews

(2013) George A Wells et al.   Research Synthesis Methods

Venous Thromboembolism in Recipients of Antipsychotics

(2012) Anna K. Jönsson et al.   CNS DRUGS

GRADE guidelines—an introduction to the 10th–13th articles in the series

(2012) Gordon H. Guyatt et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Antipsychotic drugs and risk of pulmonary embolism

(2011) Benoit Allenet et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Antipsychotics and Venous Thromboembolism Risk: A Meta-Analysis

(2011) R. Zhang et al.   PHARMACOPSYCHIATRY

Multiple Myeloma, Venous Thromboembolism, and Treatment-Related Risk of Thrombosis

(2011) Elena Zamagni et al.   SEMINARS IN THROMBOSIS AND HEMOSTASIS

Incidence and Characteristics of Venous Thromboembolic Disease During Pregnancy and the Postnatal Period: A Contemporary Series

(2010) David J. O'Connor et al.   ANNALS OF VASCULAR SURGERY

Antipsychotic Drug Use and the Risk of Venous Thromboembolism in Elderly Patients

(2010) Bart C. Kleijer et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Challenges in Developing Evidence-Based Recommendations Using the GRADE Approach: The Case of Mental, Neurological, and Substance Use Disorders

(2010) Corrado Barbui et al.   PLOS MEDICINE

Antipsychotics and risk of venous thromboembolism: A population-based case-control study

(2010) Anna Jönsson   Clinical Epidemiology

Risk of venous thromboembolism due to antipsychotic drug therapy

(2009) Staffan Hägg et al.   Expert Opinion On Drug Safety

Antipsychotics associated with pulmonary embolism in a Swedish medicolegal autopsy series

(2009) Anna K. Jönsson et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

Long-Term Interleukin-6 Levels and Subsequent Risk of Coronary Heart Disease: Two New Prospective Studies and a Systematic Review

(2008) John Danesh et al.   PLOS MEDICINE